Marathon CEO Placed Steep Price Hikes on Drugs Before Emflaza

The CEO of the latest drugmaker to face criticism over a product’s high price has a history of steep hikes on other drugs and at past companies. Marathon Pharmaceuticals LLC Chief Executive Officer Jeffrey Aronin, under fire for setting an $89,000 price on the company’s drug for a rare, deadly muscle disease, was questioned in a letter more than two years ago by Washington lawmakers about mark-ups on two heart drugs.

Democrats say Trump’s Washington hotel lost money pre-election, push for GSA action

Sen. Elizabeth Warren wants answers from the General Services Administration about possible violations of Trump’s Washington hotel lease. Leading Democrats on Capitol Hill say President Trump’s Washington hotel lost more than $1.1 million in the first two months of operations and renewed their assertions Monday that the project has violated its lease with the federal government and raised untenable conflicts of interest.